Freenome
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3300 Marina Blvd, Brisbane, California, ...Phone Number
(650) 446-6630Website
www.freenome.comRevenue
$30.4 MillionStock Symbol
FRNMIndustry
About Freenome
Freenome Holdings, Inc. is a biotechnology company headquartered in Brisbane, California, focused on early cancer detection. Founded in 2014, the company develops blood-based cancer screening tests that combine multiomics, artificial intelligence, and machine learning to detect cancer at early stages using a standard blood draw. Its platform analyzes cell-free DNA, RNA, and proteins, with its SimpleScreen portfolio initially targeting colorectal cancer and advanced adenomas. Freenome partners with pharmaceutical companies, health systems, and academic institutions and became publicly traded on Nasdaq under the ticker FRNM following a recent business combination.Explore more
Freenome Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Freenome
Compare insights from companies similar to Freenome, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Freenome Tech Stack
A closer look at the technologies used by Freenome
See more technologies
Top Business Services Companies
Frequently Asked Questions Regarding Freenome
Sign Up For FreeTo access detailed company insights
Freenome Holdings, Inc. is a biotechnology company headquartered in Brisbane, California, focused on early cancer detection. Founded in 2014, the company develops blood-based cancer screening tests that combine multiomics, artificial intelligence, and machine learning to detect cancer at early stages using a standard blood draw. Its platform analyz... Read More
